Venofer and Emtriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Venofer (iron sucrose) and Emtriva (emtricitabine). Common drug interactions include anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Venofer and Emtriva. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Venofer?

Venofer has active ingredients of iron sucrose. It is often used in anemia. eHealthMe is studying from 8,895 Venofer users. Check the latest studies of Venofer.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.



On Aug, 09, 2026

11 people who take Venofer and Emtriva together, and have interactions are studied.

Venofer and Emtriva drug interactions.

What are the common drug interactions of Venofer and Emtriva, by gender? *:

female:

n/a

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Bipolar disorder (mood disorder)
  7. Blood creatinine increased
  8. Deformity (disfigurement)
  9. Dyspnoea (difficult or laboured respiration)
  10. Gait disturbance

What are the common drug interactions of Venofer and Emtriva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Decreased activity
  5. Emotional distress
  6. Fatigue (feeling of tiredness)
  7. Pain
  8. Quality of life decreased
  9. Gait disturbance
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Bipolar disorder (mood disorder)
  6. Deformity (disfigurement)
  7. Depression
  8. Emotional distress
  9. General physical health deterioration (weak health status)
  10. Injury

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood creatinine increased
  4. Emotional distress
  5. Glomerular filtration rate decreased
  6. Pain
  7. Dyspnoea (difficult or laboured respiration)
  8. Gait disturbance

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fluid overload (too much fluid in the blood)
  3. Hypertension (high blood pressure)
  4. Seminoma (a germ cell tumour of the testis)

60+:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Anxiety
  5. Decreased activity
  6. Depression
  7. Emotional distress
  8. Fatigue (feeling of tiredness)
  9. Pain
  10. Quality of life decreased

What are the existing conditions these people have? *

  1. Hiv Infection: 9 people, 81.82%
  2. High Blood Pressure: 4 people, 36.36%
  3. Anaemia (lack of blood): 4 people, 36.36%
  4. Thyroid Diseases: 2 people, 18.18%
  5. Stress And Anxiety: 2 people, 18.18%
  6. Pain: 2 people, 18.18%
  7. Neuropathy Peripheral (surface nerve damage): 2 people, 18.18%
  8. Nephropathy (damage to or disease of a kidney): 2 people, 18.18%
  9. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 18.18%
  10. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Venofer and Emtriva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Venofer and Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Venofer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Venofer and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emtriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on iron sucrose and emtricitabine (the active ingredients of Venofer and Emtriva, respectively), and Venofer and Emtriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: